FDA Approvals - Barr Confirms Patent Challenge of Aggrenox(R) (The San Francisco Examiner)
Barr Confirms Patent Challenge of Aggrenox(R) (The San Francisco Examiner)
Jul 12, 2007 12:42 PM (54 mins ago) From Barr Pharmaceuticals, Inc., Distributed by PR Newswire
Aurobindo Pharma Selects MetricStream For Compliance And Quality (PharmaceuticalOnline)
MetricStream, Inc., the market leader in enterprise-wide Governance, Risk, Compliance (GRC) and Quality Management solutions, announced that Aurobindo Pharma (INDIA: AUROPHARMA) has selected the MetricStream solution to automate its compliance processes for meeting FDA cGMP regulations.
Oscient Pharmaceuticals Provides Preliminary Revenue Results for the Second Quarter of 2007 (Business Wire via Yahoo! Finance)
WALTHAM, Mass.----Oscient Pharmaceuticals Corporation today announced preliminary revenue results for the second quarter of 2007. The Company expects to record total revenues of approximately $15 - $16 million in the second quarter of 2007, compared to $4.6 million in total revenues in the second quarter of 2006, prior to the acquisition of ANTARA capsules in August 2006.